Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand

@inproceedings{Jia2012TargetingBT,
  title={Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand},
  author={Xing-you Jia and Qi Yu and Zhe-Hui Zhang and Xiao-feng Yang},
  booktitle={OncoTargets and therapy},
  year={2012}
}
OBJECTIVE To study the practicality of the FITC-CSNRDARRC peptide ligand (containing the Cys-Ser-Asn-Arg-Asp-Ala-Arg-Arg-Cys nonapeptide) in diagnosing and monitoring bladder tumors. MATERIALS AND METHODS Between March 2011 and September 2011, 80 consecutive patients with radiographic abnormalities, localizing hematuria, other symptoms, or signs were studied using the FITC-CSNRDARRC ligand, urinary cytology (UC), and fluorescence in situ hybridization (FISH). The sensitivity and specificity… CONTINUE READING

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Clinical usefulness of fluorescence in situ hybridization for diagnosis and surveillance of bladder cancer

Song M-J, Lee H-M, Kim S-H
  • Cancer Genet Cytogenet
  • 2010
VIEW 1 EXCERPT